This pipeline inspects significant overlapping pathway gene sets for a given gene list using a hypergeometric test. For the gene set database, we uses GSEA MSigDB Class2: Canonical Pathways DB as a gene set data. Further details about the MsigDB gene sets, please visit The Broad Institute GSEA MsigDB
For a given gene list, a hypergeometric test was tried to find significant overlapping canonical pathways using 1320 gene sets. In terms of FDR adjusted p.values, top 5 significant overlapping gene sets are listed as below.
-
KEGG_PROSTATE_CANCER, KEGG_PATHWAYS_IN_CANCER, REACTOME_DEVELOPMENTAL_BIOLOGY, KEGG_ENDOMETRIAL_CANCER, KEGG_MELANOMA
GS(gene set) pathway name | gene.list | GS size (m) | n.NotInGS (n) | Gene universe (N) | n.drawn (k) | n.found (x) | p.value (p(X>=x)) | FDR (q.value) |
---|---|---|---|---|---|---|---|---|
KEGG PROSTATE CANCER | gene.list | 89 | 45867 | 45956 | 91 | 8 | 1.069e-11 | 1.411e-08 |
KEGG PATHWAYS IN CANCER | gene.list | 328 | 45628 | 45956 | 91 | 11 | 5.897e-11 | 3.892e-08 |
REACTOME DEVELOPMENTAL BIOLOGY | gene.list | 396 | 45560 | 45956 | 91 | 11 | 4.326e-10 | 1.904e-07 |
KEGG ENDOMETRIAL CANCER | gene.list | 52 | 45904 | 45956 | 91 | 6 | 9.645e-10 | 3.183e-07 |
KEGG MELANOMA | gene.list | 71 | 45885 | 45956 | 91 | 6 | 6.584e-09 | 1.716e-06 |
KEGG CHRONIC MYELOID LEUKEMIA | gene.list | 73 | 45883 | 45956 | 91 | 6 | 7.801e-09 | 1.716e-06 |
PID SMAD2 3NUCLEARPATHWAY | gene.list | 82 | 45874 | 45956 | 91 | 6 | 1.582e-08 | 2.983e-06 |
KEGG BLADDER CANCER | gene.list | 42 | 45914 | 45956 | 91 | 5 | 2.187e-08 | 3.608e-06 |
PID HES HEYPATHWAY | gene.list | 48 | 45908 | 45956 | 91 | 5 | 4.360e-08 | 6.395e-06 |
KEGG NON SMALL CELL LUNG CANCER | gene.list | 54 | 45902 | 45956 | 91 | 5 | 7.978e-08 | 1.053e-05 |
BIOCARTA CTCF PATHWAY | gene.list | 23 | 45933 | 45956 | 91 | 4 | 1.237e-07 | 1.485e-05 |
KEGG NEUROTROPHIN SIGNALING PATHWAY | gene.list | 126 | 45830 | 45956 | 91 | 6 | 2.075e-07 | 1.961e-05 |
KEGG GLIOMA | gene.list | 65 | 45891 | 45956 | 91 | 5 | 2.048e-07 | 1.961e-05 |
BIOCARTA RACCYCD PATHWAY | gene.list | 26 | 45930 | 45956 | 91 | 4 | 2.080e-07 | 1.961e-05 |
KEGG PANCREATIC CANCER | gene.list | 70 | 45886 | 45956 | 91 | 5 | 2.978e-07 | 2.312e-05 |
PID CDC42 PATHWAY | gene.list | 70 | 45886 | 45956 | 91 | 5 | 2.978e-07 | 2.312e-05 |
PID AP1 PATHWAY | gene.list | 70 | 45886 | 45956 | 91 | 5 | 2.978e-07 | 2.312e-05 |
REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | gene.list | 72 | 45884 | 45956 | 91 | 5 | 3.432e-07 | 2.384e-05 |
REACTOME IMMUNE SYSTEM | gene.list | 933 | 45023 | 45956 | 91 | 12 | 3.319e-07 | 2.384e-05 |
PID MET PATHWAY | gene.list | 80 | 45876 | 45956 | 91 | 5 | 5.824e-07 | 3.844e-05 |
-
Gene set database = c2.cp.v4.0.symbols.gmt
-
Input gene list = MutSig2CV.input.genenames.txt
For a given gene list, it uses a hypergeometric test to get a significance of each overlapping pathway gene set. The hypergeometric p-value is obtained by R library function phyper() and is defined as a probability of randomly drawing x or more successes(gene matches) from the population consisting N genes in k(the input genes) total draws.
-
a cumulative p-value using the R function phyper():
-
ex). a probability to see at least x genes in the group is defined as p(X>=x) = 1 - p(X<=x)= 1 - phyper(x-1, m, n, k, lower.tail=FALSE, log.p=FALSE) that is, f(x| N, m, k) = (m) C (k) * ((N-m) C (n-k)) / ((N) C (n))
-
The hypergeometric test is identical to the corresponding one-tailed version of Fisher's exact test.
-
ex). Fisher' exact test = matrix(c(n.Found, n.GS-n.Found, n.drawn-n.Found, n.NotGS- (n.drawn-n.Found)), nrow=2, dimnames = list(inputGenes = c("Found", "NotFound"),GeneUniverse = c("GS", "nonGS")) )
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.